首页> 外文期刊>Drug testing and analysis >A high-throughput and broad-spectrum screening method for analysing over 120 drugs in horse urine using liquid chromatography-high-resolution mass spectrometry
【24h】

A high-throughput and broad-spectrum screening method for analysing over 120 drugs in horse urine using liquid chromatography-high-resolution mass spectrometry

机译:使用液相色谱 - 高分辨率质谱法分析马尿中120多种药物的高通量和广谱筛选方法

获取原文
获取原文并翻译 | 示例
           

摘要

A high-throughput method has been developed for the doping control analysis of 124 drug targets, processing up to 154 horse urine samples in as short as 4.5 h, from the time the samples arrive at the laboratory to the reporting deadline of 30 min before the first race, including sample receipt and registration, preparation and instrument analysis and data vetting time. Sample preparation involves a brief enzyme hydrolysis step (30 min) to detect both free and glucuronide-conjugated drug targets. This is followed by extraction using solid-supported liquid extraction (SLE) and analysis using liquid chromatography-high-resolution mass spectrometry (LC-HRMS). The entire set-up comprised of four sets of Biotage Extrahera automation systems for conducting SLE and five to six sets of Orbitrap for instrumental screening using LC-HRMS. Suspicious samples flagged were subject to confirmatory analyses using liquid chromatography-triple quadrupole mass spectrometry. The method comprises 124 drug targets from a spectrum of 41 drug classes covering acidic, basic and neutral drugs. More than 85% of the targets had limits of detection at or below 5 ng/mL in horse urine, with the lowest at 0.02 ng/mL. The method was validated for qualitative identification, including specificity, sensitivity, extraction recovery and precision. Method applicability was demonstrated by the successful detection of different drugs, namely (a) butorphanol, (b) dexamethasone, (c) diclofenac, (d) flunixin and (e) phenylbutazone, in post-race or out-of-competition urine samples collected from racehorses. This method was developed for pre-race urine testing in Hong Kong; however, it is also suitable for testing post-race or out-of-competition urine samples, especially when a quick total analysis time is desired.
机译:已经开发出高通量的方法,用于124种药物靶标的掺杂控制分析,加工高达154马尿样,短至4.5小时,从样品到达实验室到报告期限30分钟之前第一场比赛,包括样品收据和注册,准备和仪器分析和数据审查时间。样品制备涉及简要的酶水解步骤(30分钟)以检测自由和葡糖醛酸缀合的药物靶标。然后使用固体支持的液体萃取(SLE)萃取,并使用液相色谱 - 高分辨率质谱(LC-HRMS)分析。整个设置包括四套Biotage Superhera自动化系统,用于使用LC-HRMS进行SLE和五到六套orbitrap,用于仪器筛选。标记的可疑样品通过使用液相色谱 - 三重四极杆质谱法进行确认分析。该方法包括来自覆盖酸性,碱性和中性药物的41种药物谱的124种药物靶标。超过85%的靶标在马尿中或在5ng / ml低于5 ng / ml的靶标有限,最低为0.02ng / ml。该方法验证了定性鉴定,包括特异性,灵敏度,提取恢复和精度。通过成功地检测不同药物的方法,即(a)丁甲醇,(b)dexamethasone,(c)二氯芬松,(d)氟芬丁蛋白和(e)苯基丁酮,在赛后或出次出次尿液样品中,所述方法适用从赛马收集。该方法是在香港赛前尿检的开发;然而,它也适用于测试赛后或尿液外尿样,特别是当需要快速的全部分析时间。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号